Medtronic Recalls HeartWare HVAD System Batteries For Electrical Faults
Medtronic Plc (NYSE:MDT) is recalling HeartWare HVAD System batteries because they may experience electrical faults that cause the system to fail…
FDA Announced Clearance To Century Therapeutics’ Allogeneic Cell Therapy Candidate Study
Century Therapeutics, Inc. (NASDAQ: IPSC) received ELiPSE-1 clinical study may proceed notification from the U.S. Food and Drug Administration (FDA) to assess CNTY-101 in patients with relapsed or refractory CD19 positive B-cell malignancies.
Bidi Vapor Wins Merits Case Against FDA; Anticipates Revenue Growth
GRANT, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive U.S. distributor of
MindMed Announces First Patient Dosed In Phase 2b Trial Of MM-120 In Generalized Anxiety Disorder
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today
Iovance Biotherapeutics Initiates Biologics License Application Submission For Lifileucel In Advanced Melanoma
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that it has initiated a rolling Biologics License Application (BLA)
Century Therapeutics Receives Study May Proceed Notification From FDA For CNTY-101
– Investigational New Drug Application for CNTY-101, a CAR-iNK product candidate targeting CD19 for B-cell malignancies, cleared by FDA –
– First cell product candidate engineered with six
AstraZeneca Announced Ultomiris Approved in Japan for gMG
Ultomiris (ravulizumab) has been approved in Japan for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive and whose symptoms are difficult to control with high-dose intravenous immunoglobulin therapy (IVIg) or plasmaphaeresis.